Search
43 studies match these filters. Showing 26–43 of 43 studies
| Registration number | Study | Status | Phase | Enrolment | Sites / countries | Start year | Last updated | Actions |
|---|---|---|---|---|---|---|---|---|
| NCT06527222 | A Study of Ranolazine in ALS The purpose of this study is to evaluate safety, effect on cramps, function and quality of life of ranolazine versus placebo for the treatment of ALS. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 6 sites in total · contact listed | Recruiting | Phase 2 | 72target | 6 / 1 | 2025 | Jun 8, 2026 | |
| NCT06492616 | A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast cancer with high risk of recurrence. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 567 sites in total · contact listed | Recruiting | Phase 3 | 4,220target | 567 / 28 | 2024 | Sep 15, 2026 | |
| NCT06937177 | Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy This is a randomized, double-blind, placebo-controlled basket trial evaluating mifomelatide (TCMCB07) administered daily by subcutaneous (SC) injection in up to 120 patients. Patients will be enrolled into two cohorts 1) patients with newly diagnosed, advanced, unresectable colorectal cancer (CRC) o… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 26 sites in total · contact listed | Recruiting | Phase 2 | 120target | 26 / 2 | 2025 | Jul 15, 2026 | |
| NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. The purpose of this study is to find out if a medicine called vicadrostat, when taken with empaglifl… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 1,143 sites in total · contact listed | Recruiting | Phase 3 | 11,800target | 1,143 / 51 | 2025 | Sep 16, 2026 | |
| NCT05485961 | Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) This is a two-part, phase 2b and phase 3 combined prospective, interventional, multicenter, randomized, double-blind, placebo-controlled study. Part 1: Phase 2b is a dose-finding study for CSL300 vs placebo. Part 2: Phase 3 aims to assess the efficacy of CSL300 vs placebo on cardiovascular (CV) out… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 557 sites in total · contact listed | Recruiting | Phase 2 / Phase 3 | 3,110target | 557 / 35 | 2022 | Aug 11, 2026 | |
| NCT07190300 | TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) The purpose of the study is to evaluate the safety, tolerability, and efficacy of the two different treatment combinations of tulmimetostat in participants with de novo or recurrent Metastatic Hormone-Sensitive Prostate Cancer (mHSPC). ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 31 sites in total · contact listed | Recruiting | Phase 1 / Phase 2 | 181target | 31 / 14 | 2026 | Jun 23, 2026 | |
| NCT04553770 | Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer This phase II trial investigates how well trastuzumab deruxtecan works alone or in combination with anastrozole in treating patients with HER2 low, hormone receptor positive breast cancer. Trastuzumab deruxtecan is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug called derux… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 9 sites in total · contact listed | Recruiting | Phase 2 | 88target | 9 / 1 | 2020 | Nov 10, 2025 | |
| NCT03723928 | S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer This randomized research trial studies how well serum tumor marker directed disease monitoring works in monitoring patients with hormone receptor positive Her2 negative breast cancer that has spread to other places in the body. Using markers to prompt when scans should be ordered may be as good as t… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 723 sites in total | Recruiting | Not applicable | 739target | 723 / 3 | 2018 | Apr 2, 2026 | |
| NCT05827081 | Phase IIIb Study of Ribociclib + ET in Early Breast Cancer The purpose of this open-label, multicenter, phase IIIb, single-arm study is to characterize the efficacy and safety of the combination of ribociclib and standard adjuvant endocrine therapy (ET) on invasive breast cancer-free survival (iBCFS), in a close to clinical practice patient population with… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 229 sites in total · contact listed | Recruiting | Phase 3 | 1,400target | 229 / 16 | 2024 | Sep 18, 2026 | |
| NCT07225946 | A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer The purpose of this study is to find out whether treatment with pasritamig and docetaxel prolongs radiographic progression free survival (rPFS) (the length of time from start of treatment until disease worsens as determined by scans or death due to any cause) when compared to treatment with docetaxe… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 152 sites in total | Recruiting | Phase 3 | 800target | 152 / 17 | 2025 | Aug 28, 2026 | |
| NCT06982521 | Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer This is a global, multicenter, open-label, randomized Phase 3 study comparing the efficacy and safety of RLY-2608 (zovegalisib) + fulvestrant to capivasertib + fulvestrant for the treatment of patients with HR+/HER2- ABC with PIK3CA mutation following recurrence or progression on or after treatment… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 231 sites in total | Recruiting | Phase 3 | 540target | 231 / 24 | 2025 | Sep 3, 2026 | |
| NCT07453069 | Effect of FB301 on Vaginal Bacterial Profile in Women With Asymptomatic Vaginal Dysbiosis Undergoing a Mock Frozen Embryo Transfer Cycle The goal of this clinical trial is to evaluate FB301 during a mock frozen embryo transfer (FET) cycle in pre-menopausal women aged 18 to 40 years with a prior failed FET and a defined vaginal bacterial imbalance (dysbiosis). The main question it aims to answer is: • Does treatment with FB301 durin… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 4 sites in total · contact listed | Recruiting | Phase 2 | 30target | 4 / 1 | 2026 | Sep 3, 2026 | |
| NCT04729114 | A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer Medicines that reduce the amount of testosterone in the body are commonly used to treat prostate cancer. PRL-02 depot is a potential treatment for men with advanced prostate cancer. It is given by an injection into the muscle. Men with advanced prostate cancer can take part in this study. Their canc… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 25 sites in total | Recruiting | Phase 1 | 174target | 25 / 2 | 2021 | Feb 4, 2026 | |
| NCT06531824 | EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) This study is open to adults with chronic kidney disease at risk of progression. People with and without type 2 diabetes can take part in this study. The study is open to people who take other medicines called angiotensin converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARB). Pe… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 557 sites in total · contact listed | Recruiting | Phase 3 | 11,000target | 557 / 20 | 2024 | Sep 17, 2026 | |
| NCT02402244 | Project: Every Child for Younger Patients With Cancer This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 279 sites in total · contact listed | Recruiting | 75,000target | 279 / 6 | 2015 | Aug 25, 2026 | ||
| NCT06906562 | A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations This phase II study evaluates how well pemigatinib works for the treatment of adult patients with pancreatic cancer that has spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or has spread from where it first started to other places in the body… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 109 sites in total · contact listed | Recruiting | Phase 2 | 40target | 109 / 1 | 2025 | Feb 17, 2026 | |
| NCT05334069 | Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 745 sites in total · contact listed | Recruiting | 2,000target | 745 / 1 | 2022 | Sep 2, 2026 | ||
| NCT03866382 | Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by blo… ✓ Contact✗ Claimed Nearest site: Kingman, Kansas, United States — 28 km away · 581 sites in total | Recruiting | Phase 2 | 314target | 581 / 2 | 2019 | Sep 16, 2026 |